- Home
- CMND vs INM Comparison
CMND vs INM Comparison
Compare CMND & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- INM
- Stock Information
- Founded
- CMND 2017
- INM 1981
- Country
- CMND Canada
- INM Canada
- Employees
- CMND N/A
- INM N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- CMND Health Care
- INM Health Care
- Exchange
- CMND Nasdaq
- INM Nasdaq
- Market Cap
- CMND 5.3M
- INM 4.3M
- IPO Year
- CMND N/A
- INM N/A
- Fundamental
- Price
- CMND $0.97
- INM $2.46
- Analyst Decision
- CMND
- INM
- Analyst Count
- CMND 0
- INM 0
- Target Price
- CMND N/A
- INM N/A
- AVG Volume (30 Days)
- CMND 2.0M
- INM 112.5K
- Earning Date
- CMND 09-11-2025
- INM 11-13-2025
- Dividend Yield
- CMND N/A
- INM N/A
- EPS Growth
- CMND N/A
- INM N/A
- EPS
- CMND N/A
- INM N/A
- Revenue
- CMND N/A
- INM $4,942,633.00
- Revenue This Year
- CMND N/A
- INM N/A
- Revenue Next Year
- CMND N/A
- INM N/A
- P/E Ratio
- CMND N/A
- INM N/A
- Revenue Growth
- CMND N/A
- INM 7.50
- 52 Week Low
- CMND $0.80
- INM $1.72
- 52 Week High
- CMND $2.18
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- CMND 39.90
- INM 51.10
- Support Level
- CMND $0.92
- INM $2.17
- Resistance Level
- CMND $1.05
- INM $2.39
- Average True Range (ATR)
- CMND 0.07
- INM 0.11
- MACD
- CMND -0.01
- INM 0.01
- Stochastic Oscillator
- CMND 7.69
- INM 47.04
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.